Baricitinib

JAK Inhibitors for Rheumatoid Arthritis

JAK Inhibitors for Rheumatoid Arthritis

Biologics have changed the landscape of therapy for rheumatoid arthritis (RA). While they have substantially improved outcomes in patients with RA who are disease-modifying antirheumatic drug (DMARD) incomplete responders (IRs), they require administration via […]